From: A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one
Matched characteristics | Pre (n = 469) | Post (n = 191) | Total (n = 660) | p-value |
---|---|---|---|---|
Age | 61.9 ± 7 | 61.5 ± 7 | 61.8 ± 7 | 0.5070* |
Race |  |  |  | 0.2244†|
 Black | 101 | 53 | 154 |  |
 Other | 45 | 18 | 63 |  |
 White | 323 | 120 | 443 |  |
BMI | 28.7 ± 4.4 | 29.4 ± 4.8 | 28.9 ± 4.6 | .0244* |
BSA | 2.13 ± 0.2 | 2.17 ± 0.2 | 2.14 ± 0.2 | .0196* |
ASA score |  |  |  | 0.6552†|
 1 | 10 | 3 | 13 |  |
 2 | 224 | 86 | 310 |  |
 3 | 233 | 102 | 335 |  |
 4 | 2 | 0 | 2 |  |
Smoker | 42 | 33 | 75 | .0042‡ |
Chronic pain (current) | 36 | 17 | 53 | 0.6362‡ |
Chronic pain | 47 | 32 | 79 | .0239‡ |
Anxiety | 14 | 10 | 24 | 0.1723‡ |
Major depression | 13 | 9 | 21 | 0.2331‡ |
Mood disorder | 0 | 0 | 0 | N/A |
Drug use disorder | 1 | 4 | 5 | .0265‡ |
Opioid tolerant | 1 | 2 | 3 | 0.2024‡ |
Sleep apnoea | 43 | 23 | 66 | 0.3162‡ |